GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TME Pharma NV (FRA:0N6A) » Definitions » 5-Year Yield-on-Cost %

TME Pharma NV (FRA:0N6A) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 16, 2025)


View and export this data going back to 2018. Start your Free Trial

What is TME Pharma NV 5-Year Yield-on-Cost %?

TME Pharma NV's yield on cost for the quarter that ended in Jun. 2024 was 0.00.


The historical rank and industry rank for TME Pharma NV's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:0N6A's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.65
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of TME Pharma NV's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, TME Pharma NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TME Pharma NV's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TME Pharma NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where TME Pharma NV's 5-Year Yield-on-Cost % falls into.


;
;

TME Pharma NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of TME Pharma NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

TME Pharma NV  (FRA:0N6A) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


TME Pharma NV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of TME Pharma NV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


TME Pharma NV Business Description

Traded in Other Exchanges
Address
Max-Dohrn-Street 8-10, Berlin, DEU, 10589
TME Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment and focusing on the improvement in the effectiveness of cancer therapies. Its product is NOX-A12 which is being developed in solid tumors. In the Phase 1/2 trial in chemotherapy-resistant 1st line glioblastoma (brain cancer) patients, NOX-12 + radiotherapy + anti-VEGF has shown a statistically survival benefit over both standard of care reference cohort (p=0.003, HR: 0.30) and as well as vs. patients receiving NOX-A12 and radiotherapy alone (p=0.021, HR: 0.34).

TME Pharma NV Headlines

No Headlines